Patents/Assignees

Zhejiang Nanomab Technology Center Co. Ltd.

1 patent in portfolio

US12442106utility2025
Sequence-based High Throughput Method Generating Camelids Antibodies to Cover Broad Epitopes with High-resolution
0 cites